Switching from Prozac to Viibryd
When switching from fluoxetine (Prozac) to vilazodone (Viibryd), allow at least 14 days after stopping fluoxetine before initiating Viibryd at 10 mg daily with food, then titrate to 20-40 mg over 1-2 weeks. This conservative approach accounts for fluoxetine's exceptionally long half-life and minimizes the risk of serotonin syndrome.
Recommended Switching Protocol
Step 1: Discontinue Fluoxetine
- Taper fluoxetine gradually if the patient has been on it long-term to minimize discontinuation symptoms 1
- For patients on 20 mg daily: Consider tapering to 10 mg for 7 days before complete discontinuation
- Note the unique pharmacology: Fluoxetine has a very long half-life (4-6 days for the parent drug, 4-16 days for the active metabolite norfluoxetine) 1, meaning it continues to exert effects for weeks after the last dose
Step 2: Washout Period
- Wait a minimum of 14 days after the last dose of fluoxetine before starting Viibryd 2
- This washout is critical because:
- Both medications are serotonergic agents
- Combining them increases risk of serotonin syndrome 3
- Fluoxetine's long half-life means significant drug remains in the system for 2+ weeks
Step 3: Initiate Viibryd
Following the 14-day washout, start Viibryd using the FDA-approved titration schedule 2:
- Week 1: 10 mg once daily with food
- Week 2: Increase to 20 mg once daily with food
- Week 3+: May increase to target dose of 40 mg once daily with food (if needed, after minimum 7 days at 20 mg)
Critical: Viibryd must be taken with food to ensure adequate absorption 2
Monitoring During the Switch
Monitor closely for:
- Serotonin syndrome symptoms (especially in first 24-48 hours after starting Viibryd): confusion, agitation, tremors, hyperreflexia, muscle rigidity, hypertension, tachycardia, diaphoresis 3
- Discontinuation symptoms from fluoxetine: Though less common than with shorter-acting SSRIs, watch for dizziness, fatigue, headaches, nausea, anxiety, irritability 3
- Suicidal ideation: Assess within 1 week of starting Viibryd, then regularly, especially in patients under 25 years 4, 5, 2
- Common Viibryd side effects: Diarrhea, nausea, dry mouth (reported in up to 55 patients in one study) 6
Alternative Approach for Urgent Situations
If a 14-day washout is clinically problematic (severe depression, high suicide risk):
- Consider hospitalization for close monitoring during a more rapid switch
- Start Viibryd at the lowest dose (10 mg) with extreme caution
- Monitor continuously for serotonin syndrome symptoms
- This approach carries higher risk and should only be used when benefits clearly outweigh risks 3
Important Caveats
Fluoxetine's unique properties complicate switching: Unlike shorter-acting SSRIs where cross-tapering may be possible, fluoxetine's 2-4 week elimination time makes overlap dangerous 1. The conservative 14-day washout is not arbitrary—it's based on fluoxetine's pharmacokinetics.
Evidence for this specific switch is limited: While research shows switching to vilazodone from SSRIs can be effective 6, 7, most studies involved shorter-acting SSRIs. The fluoxetine-to-vilazodone switch requires extrapolation from general switching principles and FDA labeling 2.
Patient factors matter: Adjust the approach for:
- CYP2D6 poor metabolizers (fluoxetine levels may be higher, requiring longer washout) 8
- Elderly patients (slower drug clearance)
- Hepatic impairment (prolonged fluoxetine elimination)
The gap in treatment during the 14-day washout poses relapse risk. Provide close clinical support, consider more frequent contact (phone or in-person), and ensure safety planning is in place 4.